Formalin-fixed, paraffin-embedded human Pancreas stained with VLDL-Receptor Monoclonal Antibody (VLDLR/1337).
Formalin-fixed, paraffin-embedded human Pancreas stained with VLDL-Receptor Monoclonal Antibody (VLDLR/1337).

Anti-VLDL-Receptor Antibody Clone VLDLR/1337

$ 199.00$ 459.00
Please Select Product Options Below To View The Catalog Number.

SKU: 7436-MSM1
Species: Human and Rat
Tested Applications: Immunohistochemistry (IHC)
Available Conjugates: Unconjugated
Isotype: Mouse IgG1
Mass Spec Validated?: Not MS Validated

Product NumberDescriptionPrice
7436-MSM1-P0 Size: 20 ug, Tag: Unconjugated $ 199.00
7436-MSM1-P1 Size: 100 ug, Tag: Unconjugated $ 429.00
7436-MSM1-P2 Size: 200 ug, Tag: Unconjugated $ 459.00
Shipping Information
In Stock.
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:

Purity:

Bioactivity (test results eg. IU/ml):


SKU: 7436-MSM1-P0
VLDL-Receptor General Information
Alternate Names
Very-low-density-lipoprotein receptor, VLDLR
Molecular Weight
143-161kDa
Chromosomal Location
9p24
Curated Database and Bioinformatic Data
Gene SymbolVLDLR
Entrez Gene ID7436
Ensemble Gene IDENSG00000147852
RefSeq Protein Accession(s)NP_001309155, NP_001018066, NP_003374, NP_001309154
RefSeq mRNA Accession(s)NM_001018056, NM_001322225, XR_001746373, NM_003383 NM_001322226
RefSeq Genomic Accession(s)NC_018920, NC_000009, NG_012741
UniProt ID(s)Q5VVF5, P98155
UniGene ID(s)Q5VVF5, P98155
HGNC ID(s)12698
Cosmic ID(s)VLDLR
KEGG Gene ID(s)hsa:7436
PharmGKB ID(s)PA37317
General Description of VLDL-Receptor.
VLDLR (very low density lipoprotein receptor) is a member of the LDL receptor gene family, which includes LDL receptor, LRP, megalin, VLDLR and ApoER2. The LDL receptor family is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar domain. VLDLR associates with RAP (receptor associated protein) during receptor folding, and RAP facilitates the secretion of the extracellular region of VLDLR. VLDLR is thought to mediate the interaction of extracellular Reelin and cytosolic mDab1 (mammalian disabled protein), which activates a tyrosine kinase. This pathway regulates the migration of neurons along the radial glial fiber network during brain development.

Human and Rat Anti-VLDL-Receptor Antibody Product Attributes

Species: Human and Rat
Tested Applications: Immunohistochemistry (IHC).
Clonality: Monoclonal
Anti-VLDL-Receptor Antibody Clone: VLDLR/1337
Clone VLDLR/1337 Host and Isotype: Mouse IgG1
Anti-Human and Rat VLDL-Receptor Positive Control Sample: HeLa or U-251 cells. Pancreas, Cerebellum, Heart or Skeletal Muscle.
Cellular Localization of Antibody Cytoplasmic
Buffer and Stabilizer: 10mM PBS with 0.05% BSA and 0.05% Azide
Antibody Concentration: 200 ug/ml
Antibody Purification Method:Protein A/G Purified
Immunogen: Recombinant human VLDLR fragment from c-terminal
Storage Conditions: Store at 2 to 8° C (refrigerate). Stable for 24 months when properly stored.

VLDL-Receptor Previously Observed Antibody Staining Patterns

Observed Subcellular, Organelle Specific Staining Data:

Anti-VLDLR antibody staining is expected to be primarily localized to the cytokinetic bridge, microtubule organizing center and vesicles. There is variability in either the signal strength or the localization of signal in cytokinetic bridge and microtubule organizing center from cell to cell. Additionally, antibody labeling in the cytokinetic bridge is dependent upon phase within the cell cycle.

Observed Antibody Staining Data By Tissue Disease Status:

Tissues from cancer patients, for instance, have their own distinct pattern of VLDL-Receptor expression as measured by anti-VLDL-Receptor antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.

Sample Type breast cancer carcinoid cervical cancer colorectal cancer endometrial cancer glioma head and neck cancer liver cancer lung cancer lymphoma melanoma ovarian cancer pancreatic cancer prostate cancer renal cancer skin cancer stomach cancer testicular cancer thyroid cancer urothelial cancer
Signal Intensity - - - - + - + ++ - - + + + + - + - - + +
VLDLR Variability ++ ++ ++ ++ ++ + ++ ++ ++ + ++ ++ ++ ++ ++ ++ ++ + ++ ++

Limitations and Warranty

enQuire Bio's VLDL-Receptor Anti-Human Monoclonal is available for Research Use Only. This antibody is guaranteed to work for a period of two years when properly stored.

There are no reviews yet.

Be the first to review “Anti-VLDL-Receptor Antibody Clone VLDLR/1337”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title

Materials

Methods

Notes


  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Chat: See lower right corner. | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

Anti-VLDL-Receptor Antibody Clone VLDLR/1337

https://enquirebio.com/wp-content/uploads/2017/10/enQuire-Bio-7436-MSM1-P0-anti-VLDL-Receptor-antibody-300x225.jpeg